Fennec Pharmaceuticals Inc
TSX:FRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fennec Pharmaceuticals Inc
TSX:FRX
|
US |
|
Innoviva Inc
NASDAQ:INVA
|
US |
|
Kratos Defense and Security Solutions Inc
NASDAQ:KTOS
|
US |
|
W
|
Williams-Sonoma Inc
XMUN:WM1
|
US |
|
G
|
Global Power Synergy PCL
SET:GPSC
|
TH |
|
PLDT Inc
XPHS:TEL
|
PH |
|
C
|
Cuscal Ltd
ASX:CCL
|
AU |
|
F
|
Friwo AG
F:CEA
|
DE |
|
I
|
IPD Group Ltd
ASX:IPG
|
AU |
|
Summerset Group Holdings Ltd
NZX:SUM
|
NZ |
|
L
|
Lenovo Group Ltd
DUS:LHL
|
CN |
|
Evolution AB (publ)
STO:EVO
|
SE |
|
G
|
Global Cannabis Applications Corp
F:2FA
|
CA |
|
Z
|
Zimmer Biomet Holdings, Inc
SIX:ZBH
|
US |
|
Unipol Assicurazioni SpA
MIL:UNI
|
IT |
|
T
|
Take-Two Interactive Software Inc
SWB:TKE
|
US |
|
S
|
Sherwin-Williams Co
DUS:SJ3
|
US |
|
H
|
Huntington Bancshares Inc
LSE:0J72
|
US |
Shareholder Yield
Current shareholder yield for FRX is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
FRX Price
Fennec Pharmaceuticals Inc
| Average Annual Return | 33.4% |
| Standard Deviation of Annual Returns | 63.67% |
| Max Drawdown | -62% |
| Market Capitalization | 383.6m CAD |
| Shares Outstanding | 27 322 100 |
| Percentage of Shares Shorted | 0.08% |
FRX Return Decomposition
Main factors of price return
Stock Splits
FRX's latest stock split occurred on Sep 5, 2014
The company executed a 1-for-3 stock split, meaning that for every 3 shares held, investors received 1 new share.
Before the split, FRX traded at 0.82 per share. Afterward, the share price was about 2.46.
The adjusted shares began trading on Sep 5, 2014. This was stock split number 4 in FRX's history, following the previous one in Aug 31, 2011.